Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002
- PMID: 15568585
Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002
Abstract
Promotion of folic acid to prevent neural Tube Defects (NTD) has been ongoing for ten years in Ireland, without a concomitant reduction in the total birth prevalence of NTD. The effectiveness of folic acid promotion as the sole means of primary prevention of NTD is therefore questionable. We examined trends in folic acid knowledge and peri-conceptional use from 1996-2002 with the aim of assessing the value of this approach. From 1996-2002, 300 women attending ante-natal clinics in Dublin hospitals annually were surveyed regarding their knowledge and use of folic acid. During the period the proportion who had heard of folic acid rose from 54% to 94% between 1996 and 2002 (c2 test for trend: p<0.001). Knowledge that folic acid can prevent NTD also rose from 21% to 66% (c2 test for trend: p<0.001). Although the proportion who took folic acid during pregnancy increased from 14% to 83% from 1996 to 2002 (c2 test for trend: p<0.001), peri-conceptional intake did not rise above 24% in any year. There is a high awareness of folic acid and its relation to NTD, which is not matched by peri-conceptional uptake. The main barrier to peri-conceptional uptake is the lack of pregnancy planning. To date promotional campaigns appear to have been ineffective in reducing the prevalence of NTD in Ireland. Consequently, fortification of staple foodstuffs is the only practical and reliable means of primary prevention of NTD.
Similar articles
-
Folic acid and prevention of neural tube defects in 2000 improved awareness--low peri-conceptional uptake.Ir Med J. 2001 Jun;94(6):180-1. Ir Med J. 2001. PMID: 11495236
-
Knowledge and use of peri-conceptional folic acid among antenatal patients.Ir Med J. 1997 Oct;90(6):236-8. Ir Med J. 1997. PMID: 9611928
-
Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area.Eur J Obstet Gynecol Reprod Biol. 2004 Aug 10;115(2):173-7. doi: 10.1016/j.ejogrb.2003.12.009. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15262351
-
[Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].Ned Tijdschr Geneeskd. 2005 Nov 12;149(46):2561-4. Ned Tijdschr Geneeskd. 2005. PMID: 16320666 Review. Dutch.
-
Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.Br J Nutr. 2009 Jul;102(2):173-80. doi: 10.1017/S0007114508149200. Epub 2008 Dec 16. Br J Nutr. 2009. PMID: 19079944 Review.
Cited by
-
A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers.Neurol Ther. 2013 Mar 22;2(1-2):1-12. doi: 10.1007/s40120-013-0007-0. eCollection 2013 Dec. Neurol Ther. 2013. PMID: 26000212 Free PMC article. Review.
-
Randomized Comparative Study of the U- and H-Type Approaches of the TVT-Secur Procedure for the Treatment of Female Stress Urinary Incontinence: One-Year Follow-Up.Korean J Urol. 2010 Apr;51(4):250-6. doi: 10.4111/kju.2010.51.4.250. Epub 2010 Apr 20. Korean J Urol. 2010. PMID: 20428427 Free PMC article.
-
Association between health beliefs and health behavior in early pregnancy.Matern Child Health J. 2011 Nov;15(8):1316-23. doi: 10.1007/s10995-010-0698-0. Matern Child Health J. 2011. PMID: 20957513
-
Use of folic acid supplements and risk of cleft lip and palate in infants: a population-based cohort study.Br J Gen Pract. 2012 Jul;62(600):e466-72. doi: 10.3399/bjgp12X652328. Br J Gen Pract. 2012. PMID: 22781994 Free PMC article.
-
Epidemiology, prenatal management, and prevention of neural tube defects.Saudi Med J. 2014 Dec;35 Suppl 1(Suppl 1):S15-28. Saudi Med J. 2014. PMID: 25551106 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous